-
Cardiac resynchronization reduces the mortality of progressive heart failure in patients with symptomatic left ventricular dysfunction and dyssynchrony.
-
Rheumatoid arthritis should be recognized as a marker of increased risk for myocardial infarction.
-
Although fibrinolytic therapy was highly successful for thrombosis of prosthetic mechanical heart valves, a high complication rate limits its use to nonsurgical candidates.
-
-
While the clinical benefit of oral N-acetylcysteine on reducing rates of contrast nephropathy for a given patient is unproven, it should be considered for all patients with abnormal renal function referred for elective coronary angiography.
-
In patients with active lymphocytic myocarditis and persistent heart failure for greater than 6 months, those with circulating cardiac autoantibodies and no viral genomes detected on myocardial biopsy are the most likely to benefit from immunosuppressive therapy.
-
Low intensity warfarin therapy effectively prevents recurrent venous thromboembolism, according to a recent study in the New England Journal of Medicine.
-
-
You have to take this referral. How many times have your admissions staff heard this line? Unfortunately, they most often hear it late on a Friday afternoon and in connection with a referral that they know or suspect is inappropriate for home care referral. How do your staff handle this situation when the referral source is the hospital with which you are affiliated?
-
Half of the population in the United States will have a chronic condition in 2020, a total of 157 million people, according to a study conducted by the Rand Corporation in 2000.1
